FDA Alerts Archive for 2023
January 9, 2023
January 27, 2023
February 1, 2023
February 2, 2023
February 8, 2023
February 9, 2023
February 13, 2023
February 14, 2023
February 23, 2023
March 3, 2023
March 22, 2023
March 31, 2023
April 13, 2023
April 26, 2023
April 27, 2023
- TruVision Health Recalls Dietary Supplement Products Because of Possible Health Risk
- Teva Initiates Voluntary Nationwide Recall of Specific Lots of Fentanyl Buccal Tablets CII Due to a Labeling Error
May 1, 2023
May 4, 2023
May 11, 2023
May 19, 2023
May 31, 2023
June 13, 2023
July 6, 2023
July 28, 2023
August 22, 2023
August 26, 2023
August 30, 2023
September 5, 2023
September 8, 2023
September 11, 2023
September 12, 2023
September 18, 2023
September 20, 2023
September 22, 2023
September 27, 2023
September 29, 2023
- Warning Regarding Use of Probiotics in Preterm Infants
- Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination
- KVK-Tech, Inc. Issues Voluntary Nationwide Recall of One Lot of Betaxolol Tablets, USP 10 mg Due to a Single Foreign Tablet Found During the Line Clearance After the Batch was Packaged
October 2, 2023
October 10, 2023
- Family Dollar Voluntary Recall of Certain Over-the-Counter Drugs and Medical Devices
- FDA Warns Patients and Health Care Providers About Potential Risks Associated With Compounded Ketamine Products
October 22, 2023
October 25, 2023
October 26, 2023
October 30, 2023
October 31, 2023
- Cardinal Health, Inc. Issues Voluntary Nationwide Recall of Certain LEADER™ Brand Eye Drops Supplied by Velocity Pharma, LLC Due to Potential Risk of Eye Infections
- The Harvard Drug Group, LLC Issues Voluntary Nationwide Recall of Certain Rugby® Laboratories Brand Eye Drops Supplied by Velocity Pharma, LLC Due to Potential Risk of Eye Infections
November 1, 2023
November 3, 2023
November 6, 2023
November 8, 2023
November 13, 2023
- Kilitch Healthcare India Limited Issues Voluntary Nationwide Recall of Various Eye Drops for Potential Safety Reasons
- KinderFarms, LLC Voluntarily Recalling all KinderMed Pain & Fever Products Due to Acetaminophen Instability
November 17, 2023
November 18, 2023
November 21, 2023
November 24, 2023
- Novartis Issues Voluntary US Nationwide Recall of Two Lots of Sandimmune® Oral Solution (Cyclosporine Oral Solution, USP), 100 mg/mL Due to Crystallization
- Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene
November 28, 2023
- FDA Investigating Serious Risk of T-cell Malignancy Following BCMA-Directed or CD19-Directed Autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies
- FDA Warns of Rare But Serious Drug Reaction to the Antiseizure Medicines Levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and Clobazam (Onfi, Sympazan)
December 9, 2023
December 13, 2023
December 14, 2023
December 21, 2023
- Hospira, Inc. Issues A Voluntary Nationwide Recall For One Lot of Bleomycin for Injection, USP 15 Units Single Dose ONCO-TAIN™ Glass Fliptop Vial Due To The Potential For Presence of Glass Particulate Matter
- Hospira, Inc. Issues A Voluntary Nationwide Recall For 4.2% Sodium Bicarbonate Injection, 8.4% Sodium Bicarbonate Injection, and Atropine Sulfate Injection Due to the Potential Presence of Glass Particulate Matter
- FDA Warns Consumers Not to Use Counterfeit Ozempic (semaglutide) Found in U.S. Drug Supply Chain
December 22, 2023
December 27, 2023
FDA Alerts archive
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.